SEATTLE, May 28, 2021, (MEDGADGET) — Global Poultry Pharmaceuticals market analysis
Overview
Poultry pharmaceuticals consists of feed additive medication, vaccines, and products that are specialized for managing metabolic, infectious or reproductive diseases, and drugs such as parasiticides.
In 2019, the global poultry pharmaceuticals market was at a valuation of US$ 5,807.2 million and is projected to attain a market valuation of US$ 10,095.6 million by 2027.
Drivers
Booming chicken consumptions is expected to boost growth of the global poultry pharmaceuticals market during the forecast period. As per a research manifested at the Chicken Marketing Summit 2018, in Florida State of the U.S., in a two-week survey, around 86% consumers had consumed a chicken snack or meal which was purchased from a super-market, and about 68% had consumed the chicken meal from a from service outlet.
For More Information, Request Sample Copy Of Business Report: https://www.coherentmarketinsights.com/insight/request-pdf/3879
Furthermore, considerable growth of the poultry sector is expected to augment growth of the global poultry pharmaceuticals market. As per the 2019 report from the National Turkey Federation and United Egg Producers, the U.S. Poultry and Egg Association, and the National Chicken Council, the poultry sector had done an overall business of US$ 495.1 billion in the U.S. and had generated around US$ 38.5 billion in profits.
In 2019, the Vaccines segment held a leading position in the global poultry pharmaceuticals market, contributing about 40.7% of market share, which was followed by feed additive and drugs segments, respectively.
Restraints
Strict regulations, lower exclusiveness of product, and generic competition are all expected to hamper growth of the global poultry pharmaceuticals market. Generally, the period of product exclusivity is just 3 to 5 years in the animal healthcare market. The shorter period of exclusivity can lead to increase in competition from OTC (over the counter) and generic products. In addition, poor vaccine production and imposition of strict regulation for approval of products will stymie growth of the global poultry pharmaceuticals market.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/3879
Furthermore, rising concerns over the usage of growth promoters and antibiotics in poultry are expected to hinder growth of the global poultry pharmaceuticals market. Growth promoter are antibiotics and hormonal constituents that are commonly used to enhance growth in meat or food producing poultry animals. With a proven evidence, these poultry antibiotics can negatively affect the human health by disturbing the intestinal flora and inducing the antimicrobial-resisting bacteria.
Opportunities
Accelerated research and development work in poultry nutrition is expected to provide a robust growth opportunities for companies operating in the global poultry pharmaceuticals market. In May 2020, researchers from Czech Republic’s Veterinary Research Institute had reported the use of TGFβ3 gene as a potential gene-maker for growth of chicken.
Furthermore, rising preference for poultry or pork to meet protein needs is expected to stimulate growth of the global poultry pharmaceutical market. According to the Philippine Statistics Authority, dressed chicken production had increased by 40% over the period of 2009-2018.
In 2019, the global poultry pharmaceuticals market had a valuation of US$ 5,337.8 million and is anticipated to attain a valuation of US$ 10,095.6 million by 2027 with a CAGR of 8.2% over the forecast period (2020-2027).
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/poultry-pharmaceuticals-market-3147
Key Takeaways
Increased inclination towards investment in vaccines is higher in backyard poultry of emerging countries. As per the study ‘Drivers of vaccination preferences to protect a low-value livestock resource: Willingness to pay for Newcastle disease vaccines by smallholder households’ published in the Journal Vaccine, January 2019, in Tanzania, the keenness to estimated pay was at US$ 2.64 for vaccination of ten chickens in comparison to the Newcastle disease virus considering the vaccine was protective for over three month.
The outbreak of SARS-CoV-2 virus has reduced the demand for poultry products and has hiked the demand for alternative plant-based meat products in various nations. Although, the transmission of virus is not scientifically proven to have link with poultry products, it has affected the sales significantly.
Competitive Landscape
Key companies contributing in the global poultry pharmaceuticals market are Boehringer Ingelheim, Zoetis, Inc., Merial Animal Health (Sanofi), , Bayer AG, Ceva Sante Animale, Avivagen Inc, Pacific GeneTech, Bimeda, Virbac, Eli Lilly and Company (Elanco Animal Health), and Merck Animal Health.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/market-insight/poultry-pharmaceuticals-market-3879
Key Developments
The focus of key companies in the market on adopting collaborative strategies to broaden their share in the market. In February 2020, the livestock products provider, Avivagen, Inc., had collaborated with INPHILCO, Inc., to supply the livestock of OxC-betaTM in Philippines.
The focus of key companies in the market on launch of newer products to extend their portfolio of products. In January 2020, U.S. Animal Health Business of Boehringer Ingelheim had launched the VAXXITEK HVT+IBD+ND, a vaccine which provides immunity against the Infectious Bursal Disease, Newcastle Disease and Marek’s Disease.
Other Exclusive Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837